ESSA PHARMA INC (EPIX) Stock Analyst Ratings
NASDAQ:EPIX - Nasdaq - CA29668H7085 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 48% to EPIX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.73. This target is 1.4% above the current price.
EPIX was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about EPIX.
In the previous month the buy percentage consensus was at a similar level.
EPIX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-04 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-11-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-11-01 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-12-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-09 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2022-05-12 | Piper Sandler | Maintains | Overweight |
| 2021-08-17 | Oppenheimer | Maintains | Outperform |
| 2021-03-04 | Piper Sandler | Initiate | Overweight |
| 2021-02-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-11 | HC Wainwright & Co. | Maintains | Buy |